Literature DB >> 14767650

Anterior chamber angle assessment using gonioscopy and ultrasound biomicroscopy.

Arun Narayanaswamy1, Lingam Vijaya, B Shantha, Mani Baskaran, A V Sathidevi, Sukumar Baluswamy.   

Abstract

PURPOSE: Comparison of anterior chamber angle measurements using ultrasound biomicroscopy (UBM) and gonioscopy.
METHODS: Five hundred subjects were evaluated for grading of angle width by the Shaffer method. UBM was done in the same group to document angle width, angle opening distance (AOD 500), and anterior chamber depth. Biometric parameters were documented in all subjects. UBM and gonioscopic findings were compared.
RESULTS: A study was conducted in 282 men and 218 women with a mean age of 57.32 +/- 12.48 years. Gonioscopic grading was used to segregate occludable (slit-like, grades 1 and 2) from nonoccludable (grades 3 and 4) angles. Subjective assessment by gonioscopy resulted in an overestimation of angle width within the occludable group when compared with values obtained by UBM. This did not affect the segregation of occludable versus nonoccludable angles by gonioscopy. Biometric parameters in eyes with occludable angles were significantly lower in comparison with eyes with nonoccludable angles, except for lens thickness. AOD 500 correlated well with angle width.
CONCLUSIONS: We concluded that clinical segregation into occludable and nonoccludable angles by an experienced observer using gonioscopy is fairly accurate. However, UBM is required for objective quantification of angles, and AOD 500 can be a reliable and standard parameter to grade angle width.

Entities:  

Mesh:

Year:  2004        PMID: 14767650     DOI: 10.1007/s10384-003-0004-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  Is combined mechanism glaucoma a distinct entity?

Authors:  Ramanjit Sihota; Sailesh Kumar; Talvir Sidhu; Neha Midha; Ajay Sharma; Suresh Yadav; Viney Gupta; Tanuj Dada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-20       Impact factor: 3.117

2.  Iris lens distance to predict the risk of intraocular pressure elevation after dark room provocative test.

Authors:  Xiaoli Liu; Yang Zhang; Lue Li; Ailing Bian; Qi Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-12       Impact factor: 3.117

3.  Distribution of anterior chamber angle measurements in South African young adults: an optical coherence tomography study.

Authors:  Nishanee Rampersad; Rekha Hansraj
Journal:  Int Ophthalmol       Date:  2022-01-05       Impact factor: 2.029

4.  Comparison of ultrasound biomicroscopy and ultrasonographic parameters in eyes with phacomorphic glaucoma and eyes with mature cataract.

Authors:  Sujata Subbiah; Philip A Thomas; C A Nelson Jesudasan
Journal:  Int Ophthalmol       Date:  2016-09-13       Impact factor: 2.031

5.  Automatic Classification of Anterior Chamber Angle Using Ultrasound Biomicroscopy and Deep Learning.

Authors:  Guohua Shi; Zhenying Jiang; Guohua Deng; Guangxing Liu; Yuan Zong; Chunhui Jiang; Qian Chen; Yi Lu; Xinhuai Sun
Journal:  Transl Vis Sci Technol       Date:  2019-08-19       Impact factor: 3.283

Review 6.  Angle imaging: advances and challenges.

Authors:  Desmond T L Quek; Monisha E Nongpiur; Shamira A Perera; Tin Aung
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

7.  High resolution iridocorneal angle imaging system by axicon lens assisted gonioscopy.

Authors:  Sandeep Menon Perinchery; Anant Shinde; Chan Yiu Fu; Xun Jie Jeesmond Hong; Mani Baskaran; Tin Aung; Vadakke Matham Murukeshan
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

Review 8.  Changing trends of imaging in angle closure evaluation.

Authors:  Syril Dorairaj; James C Tsai; Tomas M Grippo
Journal:  ISRN Ophthalmol       Date:  2012-05-13

9.  Ultrasound biomicroscopic findings of the iridocorneal angle in live healthy and glaucomatous dogs.

Authors:  Takashi Hasegawa; Manabu Kawata; Mitsuharu Ota
Journal:  J Vet Med Sci       Date:  2015-07-24       Impact factor: 1.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.